Phase 3 Study of EBI-005 in Dry Eye Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

670

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Dry Eye Disease (DED)
Interventions
DRUG

Active Comparator EBI-005

DRUG

Placebo Comparator

Trial Locations (45)

10036

Investigational Site, New York

11793

Investigational Site, Wantagh

14618

Investigational Site, Rochester

15213

Investigational Site, Pittsburgh

16066

Investigational Site, Cranberry Township

17601

Investigational Site, Lancaster

23502

Investigational Site, Norfolk

27262

Investigational Site, High Point

30076

Investigational Site, Roswell

33324

Investigational Site, Plantation

38119

Investigational Site, Memphis

40206

Investigational Site, Louisville

40217

Investigational Site, Louisville

40509

Investigational Site, Lexington

44115

Investigational Site, Cleveland

46260

Investigational Site, Indianapolis

46290

Investigational Site, Indianapolis

47150

Investigational Site, New Albany

57701

Investigational Site, Rapid City

60108

Investigational Site, Bloomingdale

63017

Investigational Site, Chesterfield

63090

Investigational Site, Washington

63131

Investigational Site, Des Peres

Investigational Site, St Louis

64111

Investigational Site, Kansas City

72212

Investigational Site, Little Rock

77034

Investigational Site, Houston

77055

Investigational Site#2, Houston

77573

Investigational Site, League City

78209

Investigational Site, San Antonio

78229

Investigational Site# 2, San Antonio

80120

Investigational Site, Littleton

85208

Investigational Site, Mesa

85225

Investigational Site, Chandler

89148

Investigational Site, Las Vegas

90505

Investigational Site, Torrence

90701

Investigational Site, Artesia

91345

Investigational Site, Mission Hills

92115

Investiational Site, San Diego

94954

Investigational Site, Petaluma

95670

Investigational Site, Rancho Cordova

06518

Investigational Site, Hamden

04401

Investigational Site, Bangor

02114

Investigational Site, Boston

01890

Investigational Site, Winchester

Sponsors
All Listed Sponsors
lead

Eleven Biotherapeutics

INDUSTRY